Abstract
We implemented an automated analysis of lexical aspects of semi-structured speech produced by three patient groups with Frontotemporal degeneration (FTD): behavioral variant FTD (n=74), semantic variant Primary Progressive Aphasia (svPPA, n=42), and nonfluent/agrammatic PPA (naPPA, n=22). With a natural language processing program, we automatically tagged part-of-speech categories of all words and rated nouns for lexical measures, and computed the cross-entropy estimation, which is a measure of word predictability. Our automated analysis was a valid reflection of manual scoring. For svPPA patients, we found fewer unique nouns and more pronouns and wh-words than in the other patient groups and the controls; high abstractness, ambiguity, frequency, and familiarity for nouns they produced; and the lowest cross-entropy estimation among the groups. These measures were associated with cortical thinning in the left temporal lobe. In naPPA patients, we found increased speech errors, which were associated with cortical thinning in the left middle frontal gyrus. bvFTD patients were similar to the controls. Our results underline distinct word use profiles in subgroups of PPA patients and validate our automated method of analyzing FTD patients’ speech.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Institutes of Health (AG017586, AG053940, AG052943, NS088341, DC013063, AG054519, AG066597, AG056054), the Institute on Aging at the University of Pennsylvania, the Alzheimer's Association (AACSF-18-567131), an anonymous donor, and the Wyncote Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of the Hospital of the University of Pennsylvania
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Audio files are not sharable as voice is patient-identifiable information
